Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections

International Journal of Antimicrobial Agents

Volumn 31, Issue SUPPL. 1, 2008, Pages 63-67

  Ha, U Syn ^a   Cho, Yong Hyun ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Escherichia coli extract; Immunostimulation; Recurrent urinary tract infections

Indexed keywords

PLACEBO; UROVAXOM;

ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIURIA; CLINICAL TRIAL; CYSTITIS; DRUG EFFICACY; DRUG SAFETY; DYSURIA; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKOCYTURIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANIMALS; CELL EXTRACTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNIZATION; URINARY TRACT INFECTIONS;

EID: 38349063025     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.018     Document Type: Article

References (23)

1. Stamm W.E., McKevitt M., Roberts P.L., and White N.J. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 13 (1991) 77-84
2. Ikaheimo R., Siitonen A., Heiskanen T., et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 22 (1996) 91-99
3. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80 (1990) 331-333
4. Romano J.M., and Kaye D. UTI in the elderly: common yet atypical. Geriatrics 36 (1981) 113-115
5. Hooton T.M. Recurrent urinary tract infection in women. Int J Antimicrob Agents 17 (2001) 259-268
6. Sobel J.D. Bacterial etiologic agents in the pathogenesis of urinary tract infection. Med Clin North Am 75 (1991) 253-273
7. Hooton T.M., Scholes D., Hughes J.P., et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335 (1996) 468-474
8. Kahlmeter G.J. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51 (2003) 69-76
9. Karlowsky J.A., Jones M.E., Thonsberrry C., Friedland I.R., and Sahm D.F. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 1672-1680
10. Wybran J., Libin M., and Schandene L. Enhancement of cytokine production and natural killer activity by an Escherichia coli extract. Onkologie 12 Suppl. 3 (1989) 22-25
11. Hockertz S. Immunomodulating effect of lysed immunoactive fractions of selected Escherichia coli strains on the macrophage system. An in vitro study. Arzneimittelforschung 40 (1990) 1068-1072 [in German]
12. Van Pham T., Kreis B., Corradin-Betz S., Bauer J., and Mauel J. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies. J Biol Response Mod 9 (1990) 231-240
13. Bessler W.G., Kleine B., Martinez Alonso C., et al. Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung 168 Suppl. (1990) 707-715
14. Bessler W.G., Beck P., Konetznick U., et al. Biological activity of bacterial surface components. Immunogenicity and immunomodulatory properties of a bacterial extract from Escherichia coli. Arzneimittelforschung 41 (1991) 274-279
15. Sedelmeier E.A., and Bessler W.G. Biological activity of bacterial cell-wall components: immunogenicity of the bacterial extract OM-89. Immunopharmacology 29 (1995) 29-36
16. Huber M., Baier W., Serr A., and Bessler W.G. Immunogenicity of an E. coli extract after oral or intraperitoneal administration: induction of antibodies against pathogenic bacterial strains. Int J Immunopharmacol 22 (2000) 57-68
17. Lee S.J., Kim S.W., Cho Y.H., and Yoon M.S. Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis. World J Urol 24 (2006) 33-38
18. Bauer H.W., Rahlfs V.W., Lauener P.A., and Blessmann G.S. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents 19 (2002) 451-456
19. Frey C., Obolensky W., and Wyss H. Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier. Urol Int 41 (1986) 444-446
20. Tammen H. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol 65 (1990) 6-9
21. Schulman C.C., Corbusier A., Michiels H., and Taenzer H.J. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150 (1993) 917-921
22. Magasi P., Panovics J., Illes A., and Nagy M. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 26 (1994) 137-140
23. Bauer H.W., Alloussi S., Egger G., Blumlein H.M., Cozma G., Schulman C.C., and Multicenter UTI Study Group. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol 47 (2005) 542-548